Tumor-infiltrating lymphocytes, such as GrB+ natural killer cells or effector T cells, are regarded as a positive prognostic marker in a clinical setting [42], while FoxP3+ regulatory T cells represent immune suppression, and are associated with an unfavorable outcome in a wide range of tumors [43]. This evidence concerns the gene GZMB and neoplasm.